It might actively contribute to oncogenic processes through DNA amplifications or chromosomal translocations of this locus containing both CCND1 and MYEOV-3′-putative enhancer (Janssen et al., 2002b; Zhou et al., 2022), potentially allowing it to influence the expression levels of other proto-oncogenes (in addition to CCND1) that may end up in the proximity of the amplified copies, thereby expanding its impact on the dynamics of cellular function in cancer. This evidence concerns the gene CCND1 and cancer.